CONMED EBITDA Margin 2010-2022 | CNMD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CONMED (CNMD) over the last 10 years. The current EBITDA margin for CONMED as of June 30, 2022 is .
CONMED EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-06-30 $1.04B $0.19B 18.04%
2022-03-31 $1.02B $0.19B 18.82%
2021-12-31 $1.01B $0.19B 19.19%
2021-09-30 $0.99B $0.18B 18.38%
2021-06-30 $0.98B $0.19B 19.00%
2021-03-31 $0.88B $0.14B 15.76%
2020-12-31 $0.86B $0.13B 15.30%
2020-09-30 $0.88B $0.14B 15.54%
2020-06-30 $0.87B $0.13B 14.70%
2020-03-31 $0.95B $0.17B 17.67%
2019-12-31 $0.96B $0.16B 17.07%
2019-09-30 $0.93B $0.15B 16.52%
2019-06-30 $0.90B $0.14B 15.33%
2019-03-31 $0.88B $0.13B 14.86%
2018-12-31 $0.86B $0.13B 15.48%
2018-09-30 $0.84B $0.13B 15.60%
2018-06-30 $0.83B $0.13B 15.94%
2018-03-31 $0.81B $0.13B 15.64%
2017-12-31 $0.80B $0.11B 13.17%
2017-09-30 $0.78B $0.09B 11.95%
2017-06-30 $0.77B $0.09B 12.03%
2017-03-31 $0.77B $0.09B 11.44%
2016-12-31 $0.76B $0.09B 12.32%
2016-09-30 $0.75B $0.09B 12.27%
2016-06-30 $0.73B $0.09B 12.26%
2016-03-31 $0.72B $0.09B 12.60%
2015-12-31 $0.72B $0.10B 13.21%
2015-09-30 $0.72B $0.10B 13.69%
2015-06-30 $0.73B $0.09B 11.93%
2015-03-31 $0.74B $0.09B 12.36%
2014-12-31 $0.74B $0.10B 13.24%
2014-09-30 $0.75B $0.10B 13.10%
2014-06-30 $0.75B $0.11B 13.96%
2014-03-31 $0.76B $0.11B 14.00%
2013-12-31 $0.76B $0.11B 13.91%
2013-09-30 $0.76B $0.11B 13.95%
2013-06-30 $0.76B $0.11B 14.55%
2013-03-31 $0.76B $0.11B 14.61%
2012-12-31 $0.77B $0.11B 14.60%
2012-09-30 $0.75B $0.11B 15.03%
2012-06-30 $0.74B $0.11B 15.34%
2012-03-31 $0.74B $0.11B 15.35%
2011-12-31 $0.73B $0.11B 15.45%
2011-09-30 $0.72B $0.11B 14.66%
2011-06-30 $0.72B $0.11B 14.54%
2011-03-31 $0.72B $0.10B 14.31%
2010-12-31 $0.71B $0.10B 13.88%
2010-09-30 $0.72B $0.10B 13.47%
2010-06-30 $0.72B $0.09B 12.03%
2010-03-31 $0.71B $0.08B 10.89%
2009-12-31 $0.70B $0.07B 10.07%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $3.073B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $73.740B 21.42
McKesson (MCK) United States $51.687B 15.01
AmerisourceBergen (ABC) United States $30.494B 13.47
West Pharmaceutical Services (WST) United States $25.090B 38.20
Laboratory Of America Holdings (LH) United States $24.019B 10.51
Cardinal Health (CAH) United States $17.095B 13.13
Cooper (COO) United States $16.392B 25.23
Invacare (IVC) United States $0.035B 0.00